Rina Falb

773 total citations · 1 hit paper
11 papers, 494 citations indexed

About

Rina Falb is a scholar working on Infectious Diseases, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Rina Falb has authored 11 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Pathology and Forensic Medicine and 5 papers in Neurology. Recurrent topics in Rina Falb's work include SARS-CoV-2 and COVID-19 Research (8 papers), Multiple Sclerosis Research Studies (8 papers) and Peripheral Neuropathies and Disorders (3 papers). Rina Falb is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Multiple Sclerosis Research Studies (8 papers) and Peripheral Neuropathies and Disorders (3 papers). Rina Falb collaborates with scholars based in Israel. Rina Falb's co-authors include Anat Achiron, Michael Gurevich, Sapir Dreyer-Alster, Mark Dolev, David Magalashvili, Shay Menascu, Shlomo Flechter, Polina Sonis, Mathilda Mandel and Gil Harari and has published in prestigious journals such as PLoS ONE, Clinical Microbiology and Infection and Neurobiology of Disease.

In The Last Decade

Rina Falb

10 papers receiving 486 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

2021 235 citations Anat Achiron, Mathilda Mandel et al. Therapeutic Advances in Neurological Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rina Falb Israel	6	394	341	218	94	60	11	494
Sapir Dreyer-Alster Israel	8	437 1.1×	423 1.2×	253 1.2×	116 1.2×	76 1.3×	21	604
Polina Sonis Israel	8	320 0.8×	269 0.8×	162 0.7×	104 1.1×	61 1.0×	14	443
Natalia Egri Spain	10	215 0.5×	16 0.0×	85 0.4×	54 0.6×	35 0.6×	21	329
Giulia Baresi Italy	4	207 0.5×	18 0.1×	60 0.3×	91 1.0×	19 0.3×	4	269
Barbara Baronio Italy	3	187 0.5×	18 0.1×	61 0.3×	81 0.9×	20 0.3×	4	258
Marianne Graninger Austria	7	237 0.6×	14 0.0×	51 0.2×	45 0.5×	24 0.4×	16	277
Laura Pérez‐Alós Denmark	12	255 0.6×	10 0.0×	55 0.3×	81 0.9×	12 0.2×	31	343
Simon Eschweiler United Kingdom	4	257 0.7×	8 0.0×	113 0.5×	192 2.0×	85 1.4×	5	449
Amos Stemmer Israel	8	278 0.7×	15 0.0×	13 0.1×	36 0.4×	201 3.4×	19	387
Tal Freund Israel	7	213 0.5×	17 0.0×	15 0.1×	126 1.3×	89 1.5×	13	299

Countries citing papers authored by Rina Falb

Since Specialization

Citations

This map shows the geographic impact of Rina Falb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Falb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Falb more than expected).

Fields of papers citing papers by Rina Falb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rina Falb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Falb. The network helps show where Rina Falb may publish in the future.

Co-authorship network of co-authors of Rina Falb

This figure shows the co-authorship network connecting the top 25 collaborators of Rina Falb. A scholar is included among the top collaborators of Rina Falb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rina Falb. Rina Falb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Achiron, Anat, Rina Falb, Shay Menascu, et al.. (2024). Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation. Neurobiology of Disease. 194. 106475–106475.

Harari, Gil, Michael Gurevich, Mark Dolev, Rina Falb, & Anat Achiron. (2023). Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study. PLoS ONE. 18(2). e0280515–e0280515. 4 indexed citations

Achiron, Anat, Mathilda Mandel, Sapir Dreyer-Alster, et al.. (2023). In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab. Multiple Sclerosis and Related Disorders. 72. 104616–104616. 3 indexed citations

Dreyer-Alster, Sapir, Shay Menascu, Mathilda Mandel, et al.. (2022). COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose. Journal of the Neurological Sciences. 434. 120155–120155. 40 indexed citations

Achiron, Anat, Mathilda Mandel, Michael Gurevich, et al.. (2022). Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod. Journal of Neurology. 269(5). 2286–2292. 27 indexed citations

Achiron, Anat, Michael Gurevich, Rina Falb, et al.. (2021). SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Clinical Microbiology and Infection. 27(9). 1349.e1–1349.e6. 26 indexed citations

Achiron, Anat, Mark Dolev, Shay Menascu, et al.. (2021). COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Multiple Sclerosis Journal. 27(6). 864–870. 146 indexed citations

Achiron, Anat, Michael Gurevich, Rina Falb, et al.. (2021). SARS-CoV-2 Antibody Dynamics and B-Cell Memory Response Over-Time in COVID-19 Convalescent Subjects. SSRN Electronic Journal. 1 indexed citations

Achiron, Anat, Mathilda Mandel, Sapir Dreyer-Alster, et al.. (2021). Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Therapeutic Advances in Neurological Disorders. 14. 4203293923–4203293923. 235 indexed citations breakdown →

10.

Achiron, Anat, Mathilda Mandel, Sapir Dreyer-Alster, et al.. (2021). Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Therapeutic Advances in Neurological Disorders. 14. 4203301170–4203301170. 4 indexed citations

11.

Gurevich, Michael, Rina Falb, David Magalashvili, et al.. (2015). Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis. BMC Neurology. 15(1). 240–240. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact